Navigation Links
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
Date:9/1/2010

NOVATO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism (SSIEM), August 31st-September 3rd in Istanbul, Turkey. Investigators reported that PKU patients taking Kuvan showed improvements in brain functioning, mood and behaviors.

"While these investigator-sponsored studies were conducted in a small number of subjects, the results indicate benefits beyond lowering blood Phe levels, and we hope to document similar neurocognitive improvements in subjects with PKU in our recently initiated Phase 3b Kuvan outcomes study," said Dr. Hank Fuchs, Chief Medical Officer of BioMarin.  "If successful, the data will be submitted in support of a label amendment."

Highlights of Investigator-Sponsored Studies:Neurocognitive findings in individuals with Phenylketonuria and treatment with sapropterin dihydrochloride (BH4) (White, et al; Washington University, St. Louis): Baseline findings indicate that executive performance is worse for subjects with PKU as compared to non-PKU subjects across a range of executive functions such as inhibitory control, strategic processing and working memory. The results of this exploratory study suggest improvements in executive abilities following treatment with sapropterin.

Brain function in individuals with PKU treated with Kuvan: Evidence from functional magnetic resonance imaging (Christ, et al; University of Missouri-Columbia, USA): At baseline, irregularities in neural activation were observed in subjects with PKU in the prefrontal cortex (PFC) and other brain regions as compared to subjects without PKU. At four weeks, two early-treated PKU participants responded to Kuvan with
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results
2. Accuray Announces Results for Fourth Quarter and Fiscal Year 2010
3. CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
4. Unilife Corporation Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2010
5. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
6. Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
7. Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC)
8. MedClean Technologies Announces Second Quarter Results
9. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results
10. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
11. China Yongxin Pharmaceuticals Reports Second Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Levi & Korsinsky is investigating the Board of ... BIIB) for possible violations of federal securities laws. The ... and/or directors have violated Sections 10(b) and 20(a) of ... 24, 2015, prior to the opening of the market, ... other things, the Company lowered its prior revenue guidance ...
(Date:8/4/2015)... 4, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August 11, ... Meridien in New York . A ... www.meipharma.com . A replay will be available approximately one hour ...
(Date:8/4/2015)... Aug. 4, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Transdermal ... to their offering. ... - an approach used to deliver drugs ... an alternative to oral,intravascular, subcutaneous and transmucosal ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... Mass., and WASHINGTON, Oct. 22 Boston,Scientific Corporation ... the SPIRIT,III Clinical Trial, which continue to support ... Express2(TM) Paclitaxel-Eluting,Coronary Stent System and add to the ... V (PROMUS(TM)) Everolimus Eluting Coronary,Stent System. An analysis ...
... (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company ... and,hepatitis C virus (HCV) infection, today announced that ... the Ministry of Health of the Republic of,Georgia ... drug,docetaxel in patients with metastatic breast cancer. The ...
Cached Medicine Technology:Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 2Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 3Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 4Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 4
(Date:8/4/2015)... ... ... Atlantic Health System, one of the largest health care organizations in New Jersey, ... their list of the 20 Best Workplaces in Health Care. , Ranked at No. ... Hospital and Atlantic Rehabilitation, is the highest-ranking company from New Jersey on the list. ...
(Date:8/4/2015)... Raton, FL (PRWEB) , ... August 04, 2015 ... ... diagnostic testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced ... but has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a ...
(Date:8/4/2015)... Angeles, California (PRWEB) , ... August 04, 2015 ... ... drawer slides to Los Angeles commercial customers. Finding reliable hardware can be ... unfortunate liabilities. When putting an office together or designing a new facility, ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... are suffering from underarm sweat. Evolutions Medical & Day Spa in Santa Barbara, ... the only non-invasive, FDA cleared treatment that permanently eliminates sweat and odor glands ...
(Date:8/4/2015)... Ohio (PRWEB) , ... August 04, 2015 , ... School ... of summer in the sun and preparing for the back-to-school scramble. Dublin, OH ... summer is the best time for the annual dental checkup. In fact, the dentist ...
Breaking Medicine News(10 mins):Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4
... 7 Pharmasset, Inc. (Nasdaq: VRUS ) ... lead development candidate from two series of purine analogs ... infection. PSI-938 is a proprietary nucleotide analog polymerase inhibitor ... for submission of an Investigational New Drug (IND) application ...
... Data Reinforces Need for Better Cord Blood Education , , ... cord blood banking, according to a study published in the ... Medicin e . In fact, ... some knowledge of cord blood banking, 74 percent considered themselves minimally ...
... offers safe, simple, effective alternative to tubal ligation , ... (Hologic or the Company) (Nasdaq: HOLX ), ... medical imaging systems and surgical products dedicated to serving ... Food and Drug Administration (FDA) has approved the Company,s ...
... ... Network , ... CO (Vocus) July 7, 2009 -- The Texas Hospital Association (THA) has ... state,s hospital members to hundreds of career Web sites., , , , ,"HEALTHeCAREERS is ...
... ... customized acne treatment products for normal and oily skin. For a limited time purchase ... A scientifically designed acne treatment, the azap Skin treatment products gently exfoliate dead skin ... to take the azap Product test visit azapskin.com. , ...
... ... be able to diagnose deep endometriosis and accurately locate lesions prior to surgery, according to ... ... magnetic resonance imaging (MRI), radiologists may be able to diagnose deep endometriosis and accurately locate ...
Cached Medicine News:Health News:Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development 2Health News:Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development 3Health News:Parent's Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 2Health News:Parent's Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 3Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 2Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 3Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 4Health News:Video: FDA Approves Hologic's Adiana(R) Permanent Contraception System 5Health News:Texas Hospital Association Endorses HEALTHeCAREERS Network 2Health News:New, More Effective Acne Treatment Program Launches 2Health News:MRI Accurately Depicts Deep Endometriosis 2Health News:MRI Accurately Depicts Deep Endometriosis 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: